Atlantic Lipid Lowering Treatment Optimization Program
Atlantic Lipid Lowering Treatment Optimization Program (ALLTOP): A Comprehensive Approach to the Treatment of Familial Hypercholesterolemia and Complex Dyslipidemias
Atlantic Health System
250 participants
Jul 1, 2024
INTERVENTIONAL
Conditions
Summary
Hypercholesterolemia is recognized as the major driver for cardiovascular morbidity and mortality. To help address this in our community, Atlantic Medical Group (AMG) formed a lipid workgroup chaired by Robert D. Fishberg, MD, and Jeffrey N. Feldman, MD. The overarching goal of the lipid workgroup is to enhance the treatment of lipid disorders in those patients with abnormal lipid levels by improving access to resources at the primary care practice level and specialty level. We aim to develop a model for primary and secondary prevention that integrates guidelines for treatment at the practice level. Our primary objective is to identify high-risk patients by utilizing the electronic health record and partnering with patients' primary care providers to provide comprehensive medical management.
Eligibility
Inclusion Criteria8
- LDL-C ≥160 mg/dL
- Untreated LDL-C ≥190 with family history of CAD
- Prior MI and currently without optimized lipid-lowering therapy
- Family history of CAD in first degree relative
- Personal history of CAD
- Untreated triglycerides \>500
- Elevated Lp(a) and/or high calcium scores
- Consenting individuals
Exclusion Criteria4
- Individuals who are pregnant
- Individuals who are incarcerated
- Individuals with a terminal illness
- Individuals who do not consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The study model will utilize the accepted standard of care while implementing key enhancements to proactively reach high-risk patients as early as possible. Wrap around comprehensive care is defined as database screening, outreach, encouraging genetic testing for participants and their family members, and provide ongoing education, medical management (e.g., adherence to FDA-approved medications), routine laboratory testing, specialist referrals, Epic referrals to integrated care support such as pharmacy, nutrition, social work, and community health), and routine follow-up either in-person or using virtual visits. Consultations with pharmacists, nutritionists and genetic counselors or specialists to manage co-morbidities may be requested.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06439654